Title: Note 1. Basis of Presentation
Accounting Policies: Except for the Provider Relief Fund (CFDA 93.498), expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
In accordance with guidance provided by the U.S. Department of Health and Human Services (DHHS), grants under the Provider Relief Fund are recognized in the Schedule based on the applicable Period, as defined. Accordingly, the Schedule for the year ended December 31, 2023 includes $64,164 of Period 5 Provider Relief Fund and American Rescue Plan Rural payments.
De Minimis Rate Used: Y
Rate Explanation: The auditee used the de minimis cost rate.
The accompanying schedule of expenditures of federal awards (the “Schedule”) includes the federal award activity of The Horizon Corporations (the Companies) under programs of the Federal government for the year ended December 31, 2023. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of the Companies, it is not intended to and does not present the financial position, changes in net assets or cash flows of the Companies.
Title: Note 2. Summary of Significant Accounting Policies
Accounting Policies: Except for the Provider Relief Fund (CFDA 93.498), expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
In accordance with guidance provided by the U.S. Department of Health and Human Services (DHHS), grants under the Provider Relief Fund are recognized in the Schedule based on the applicable Period, as defined. Accordingly, the Schedule for the year ended December 31, 2023 includes $64,164 of Period 5 Provider Relief Fund and American Rescue Plan Rural payments.
De Minimis Rate Used: Y
Rate Explanation: The auditee used the de minimis cost rate.
Except for the Provider Relief Fund (CFDA 93.498), expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
In accordance with guidance provided by the U.S. Department of Health and Human Services (DHHS), grants under the Provider Relief Fund are recognized in the Schedule based on the applicable Period, as defined. Accordingly, the Schedule for the year ended December 31, 2023 includes $64,164 of Period 5 Provider Relief Fund and American Rescue Plan Rural payments.
Title: Note 3. Indirect Cost Rate
Accounting Policies: Except for the Provider Relief Fund (CFDA 93.498), expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
In accordance with guidance provided by the U.S. Department of Health and Human Services (DHHS), grants under the Provider Relief Fund are recognized in the Schedule based on the applicable Period, as defined. Accordingly, the Schedule for the year ended December 31, 2023 includes $64,164 of Period 5 Provider Relief Fund and American Rescue Plan Rural payments.
De Minimis Rate Used: Y
Rate Explanation: The auditee used the de minimis cost rate.
The Companies have elected to use the 10 percent de minimis indirect cost rate as allowed under the Uniform Guidance.
Title: Note 4. Restatement of Schedule of Expenditures of Federal Awards
Accounting Policies: Except for the Provider Relief Fund (CFDA 93.498), expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
In accordance with guidance provided by the U.S. Department of Health and Human Services (DHHS), grants under the Provider Relief Fund are recognized in the Schedule based on the applicable Period, as defined. Accordingly, the Schedule for the year ended December 31, 2023 includes $64,164 of Period 5 Provider Relief Fund and American Rescue Plan Rural payments.
De Minimis Rate Used: Y
Rate Explanation: The auditee used the de minimis cost rate.
Subsequent to the original issuance of the combined financial statements and related schedule of expenditures of federal awards (the Schedule) on May 22, 2024, management determined that $1,224,086 of expenditures were inadvertently omitted from the program Block Grant for Prevention and Treatment of Substance Abuse (CFDA 93.959) passed through the New York State Office of Addiction Services and Support. The Schedule has been restated to include the previously omitted expenditures.